US healthcare major Viatris-owned Mylan has launched a ₹3,481-crore ($365 million) block deal to sell its 5.64% stake in Biocon, Moneycontrol reported. The floor price is ₹378.50 per share, a 7.9% discount to Biocon's July 13 closing price. Mylan had acquired the stake through a share swap while their block deal is scheduled to take place on July 14.